Morrell Andrew, Placzek Michael, Parmley Seth, Grella Brian, Antony Smitha, Pommier Yves, Cushman Mark
Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Purdue Cancer Center, Purdue University, West Lafayette, Indiana 47907, USA.
J Med Chem. 2007 Sep 6;50(18):4388-404. doi: 10.1021/jm070307+. Epub 2007 Aug 4.
Two series of indenoisoquinoline topoisomerase I inhibitors have been prepared to investigate optimal substituents on the indenone ring at the 9-position. The more exhaustive series was prepared using a nitrated isoquinoline ring that has been previously demonstrated to enhance biological activity. After preliminary biological evaluation, a more focused series of inhibitors was prepared utilizing a 2,3-dimethoxy-substituted isoquinoline ring. The results of the two series indicate the existence of superior functional groups such as methoxy, fluorine, and cyano for the indenoisoquinoline 9-position. Interestingly, these functional groups coincide with established structure-activity relationships for the 11-position of camptothecin.
已经制备了两系列茚并异喹啉拓扑异构酶I抑制剂,以研究茚酮环9位上的最佳取代基。更详尽的系列是使用硝化异喹啉环制备的,该环先前已被证明可增强生物活性。经过初步生物学评估后,利用2,3-二甲氧基取代的异喹啉环制备了更具针对性的抑制剂系列。这两个系列的结果表明,对于茚并异喹啉的9位,存在诸如甲氧基、氟和氰基等更优的官能团。有趣的是,这些官能团与喜树碱11位已确立的构效关系相吻合。